214 related articles for article (PubMed ID: 26385103)
1. Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.
Bankaitis KV; Fingleton B
Clin Exp Metastasis; 2015 Dec; 32(8):847-56. PubMed ID: 26385103
[TBL] [Abstract][Full Text] [Related]
2. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
4. Roles for the interleukin-4 receptor and associated JAK/STAT proteins in human articular chondrocyte mechanotransduction.
Millward-Sadler SJ; Khan NS; Bracher MG; Wright MO; Salter DM
Osteoarthritis Cartilage; 2006 Oct; 14(10):991-1001. PubMed ID: 16682236
[TBL] [Abstract][Full Text] [Related]
5. IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways.
Venmar KT; Carter KJ; Hwang DG; Dozier EA; Fingleton B
Cancer Res; 2014 Aug; 74(16):4329-40. PubMed ID: 24947041
[TBL] [Abstract][Full Text] [Related]
6. IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors.
Jin Q; Yang H; Jing Z; Hong-Hua W; Ben-Jing S; Li-Ting W; Li-Juan Y; Wei X; Xia K; Juan W; Wei Z
Mol Med; 2021 Dec; 27(1):152. PubMed ID: 34863091
[TBL] [Abstract][Full Text] [Related]
7. JAK3 associates with the human interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering.
Rolling C; Treton D; Beckmann P; Galanaud P; Richard Y
Oncogene; 1995 May; 10(9):1757-61. PubMed ID: 7538655
[TBL] [Abstract][Full Text] [Related]
8. IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity.
Vadevoo SMP; Kim JE; Gunassekaran GR; Jung HK; Chi L; Kim DE; Lee SH; Im SH; Lee B
Mol Cancer Ther; 2017 Dec; 16(12):2803-2816. PubMed ID: 28878029
[TBL] [Abstract][Full Text] [Related]
9. Lessons from immunology: IL4R directly promotes mammary tumor metastasis.
Venmar KT; Fingleton B
Oncoimmunology; 2014 Oct; 3(9):e955373. PubMed ID: 25941616
[TBL] [Abstract][Full Text] [Related]
10. Type II Interleukin-4 Receptor Activation in Basal Breast Cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation.
Williams D; Hargrove-Wiley E; Bindeman W; Valent D; Miranda AX; Beckstead J; Fingleton B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731867
[TBL] [Abstract][Full Text] [Related]
11. Association between the polymorphisms of interleukin-4, the interleukin-4 receptor gene and asthma.
Zhu N; Gong Y; Chen XD; Zhang J; Long F; He J; Xia JW; Dong L
Chin Med J (Engl); 2013; 126(15):2943-51. PubMed ID: 23924473
[TBL] [Abstract][Full Text] [Related]
12. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.
Krabben A; Wilson AG; de Rooy DP; Zhernakova A; Brouwer E; Lindqvist E; Saxne T; Stoeken G; van Nies JA; Knevel R; Huizinga TW; Toes R; Gregersen PK; van der Helm-van Mil AH
Arthritis Rheum; 2013 Dec; 65(12):3051-7. PubMed ID: 23983153
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk.
Landi S; Bottari F; Gemignani F; Gioia-Patricola L; Guino E; Osorio A; de Oca J; Capella G; Canzian F; Moreno V;
Eur J Cancer; 2007 Mar; 43(4):762-8. PubMed ID: 17258448
[TBL] [Abstract][Full Text] [Related]
15. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes.
Garrone P; Djossou O; Galizzi JP; Banchereau J
Eur J Immunol; 1991 Jun; 21(6):1365-9. PubMed ID: 1828424
[TBL] [Abstract][Full Text] [Related]
16. Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
Sampson JH; Singh Achrol A; Aghi MK; Bankiewicz K; Bexon M; Brem S; Brenner A; Chandhasin C; Chowdhary S; Coello M; Ellingson BM; Floyd JR; Han S; Kesari S; Mardor Y; Merchant F; Merchant N; Randazzo D; Vogelbaum M; Vrionis F; Wembacher-Schroeder E; Zabek M; Butowski N
Neuro Oncol; 2023 Jun; 25(6):1085-1097. PubMed ID: 36640127
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
Maeda S; Yanagihara Y
Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene polymorphisms in Tunisian endemic pemphigus foliaceus: a possible role of il-4 variants.
Toumi A; Abida O; Ben Ayed M; Masmoudi A; Turki H; Masmoudi H
Hum Immunol; 2013 May; 74(5):658-65. PubMed ID: 23376457
[TBL] [Abstract][Full Text] [Related]
19. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
[TBL] [Abstract][Full Text] [Related]
20. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition.
Gaggianesi M; Turdo A; Chinnici A; Lipari E; Apuzzo T; Benfante A; Sperduti I; Di Franco S; Meraviglia S; Lo Presti E; Dieli F; Caputo V; Militello G; Vieni S; Stassi G; Todaro M
Cancer Res; 2017 Jun; 77(12):3268-3279. PubMed ID: 28400477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
